Category: JCN Newswire

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - TOPPAN Inc. and NTT DOCOMO, Inc. announced today that they have signed a basic agreement that will allow them to jointly develop groundbreaking communication services for the forthcoming 6G era.TOPPAN is drawing on its expertise in information processing and computer graphics to deliver a wide variety of metaverse services. Concurrently, DOCOMO is spearheading development of next-generation communication technologies with its FEEL TECH platform, designed to extend human sensory experiences through networks, offering entirely new value for the 6G era.Under the terms of this agreement, TOPPAN will integrate its metaverse and advanced expression capabilities with DOCOMO's FEEL TECH platform. The two companies will subsequently collaborate in the development and provision of services in the fields of education, skill transmission, and online shopping.The first step in the process will be the integration of FEEL TECH with TOPPAN's metaverse app Metapa, which features educational content for museums designed for interactive learning. Development discussions will commence in April 2025. By incorporating FEEL TECH's sensory sharing capabilities into Metapa, both companies aim to develop next-generation content that will allow users to experience the texture of materials and tactile sensations of artists, enhancing art education through direct interaction.Going forward, TOPPAN and DOCOMO will remain dedicated to advancing efforts to deliver next-generation services that surprise and delight customers, using FEEL TECH. Copyright 2025 JCN Newswire via SeaPRwire.com.

Kawasaki and Tokyo, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Rakuten Mobile, Japan’s newest and most modern mobile network, today announced it will begin deploying base stations utilizing radio units (RU) developed by Fujitsu Limited, as it accelerates the expansion of its 5G (Sub6) network area in 2025.Leveraging its expertise in building a fully virtualized, cloud-native mobile network based on Open RAN standards in Japan, Rakuten Mobile will continue to rapidly deploy 5G Sub6 base stations and expand its coverage area. Fujitsu, through its compact and energy-efficient RU, will support Rakuten Mobile’s rollout of 5G commercial services and contribute to the further global adoption of Open RAN.The RU model to be used by Rakuten Mobile, 44R21, adopts the O-RAN specifications established by the O-RAN ALLIANCE – a worldwide community promoting the development of Open RAN specifications. The RU facilitates communication between the base station's distributed unit (DU) and centralized unit (CU) via a fronthaul interface (1). It has a proven track record of interoperability with equipment from various domestic and international vendors, enabling telecommunications carriers to diversify their equipment choices and mitigate supply chain risks. Additionally, using Fujitsu’s proprietary technology, the radio units are designed to be compact, lightweight and energy-efficient, thereby contributing to leaner space requirements and lower network operation costs.The RU 44R21 base model will be showcased at MWC Barcelona 2025, the world’s largest connectivity exhibition, held in Barcelona, Spain, from March 3 to 6, 2025.Going forward, Rakuten Mobile will use its pioneering virtualization network technology and existing base station infrastructure to reduce lead times from construction to operation, ensuring cost-efficient deployments of base stations. Additionally, Rakuten Symphony will work together with Fujitsu to discuss future collaborations, aiming to drive the global rollout of these units and accelerate the worldwide adoption of Open RAN technology.Sharad Sriwastawa, co-CEO and CTO of Rakuten Mobile, commented, "We are excited to partner with Fujitsu to accelerate the rollout of high-performance, energy-efficient 5G base stations. This collaboration will enable us to deliver exceptional mobile services to even more of our customers."Masaaki Moribayashi, Corporate Executive Officer and SEVP, Network Business and Special Assignment of Fujitsu Limited, commented, "Fujitsu’s focus has been to develop an innovative wireless platform that is compact, lightweight, and energy-efficient. In addition to this wireless device that complies with O-RAN standard specifications, Fujitsu will support Rakuten Mobile in building a flexible and efficient network, leveraging its extensive experience in O-RAN connectivity."(1) Fronthaul refers to the network that connects the control equipment and radio units that make up a base station.Product names, service names, and other names mentioned in this press release are generally trademarks or registered trademarks of their respective companies. Trademark symbols such as (TM) and (R) may be omitted in this press release.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.About Rakuten MobileRakuten Mobile, Inc. is a Rakuten Group company responsible for mobile communications, centered on its mobile network operator (MNO) business. Through continuous innovation and the deployment of advanced technology, Rakuten Mobile aims to redefine expectations in the mobile communications industry in order to provide appealing and convenient services for diverse customer needs.Press ContactsRakuten Mobile, Inc.Corporate Communications DepartmentE-mail: global-pr@mail.rakuten.comFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

KAWASAKI, Japan, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu today announced the launch of the Fujitsu Network 1FINITY™ P300 800G ZR/ZR+ coherent pluggable transceiver, an open, high-performance and sustainable key component for optical networking solutions. The transceivers, globally available from the second half of 2025, are compatible with third-party routers, Fujitsu’s Edge Networking portfolio, or in 1FINITY T-series transponder applications, offering flexible deployment options to optimize performance, cost, and power consumption according to the needs of network owners.Featuring the latest 3nm digital signal processor (DSP) semiconductor technology, in addition to pluggable support built-in to the Virtuora® network control solution, the transceivers enable high-performance operation with 30% power per bit reduction and lower costs versus previous pluggable generations. Being made in Japan, the P300 800G coherent pluggable offers high-quality precision components and supply chain resiliency. Compliant with open optical networking standards OIF ZR and Open ROADM MSA, the P-series portfolio will offer a future evolution path to data rates of 1.6 terabits per second (Tbps) and beyond.The 1FINITY P300 will be exhibited at the Fujitsu booth at MWC Barcelona 2025, the world's largest connectivity exhibition, held in Barcelona, Spain, from March 3rd to 6th and at OFC 2025 in San Francisco, California from April 1st to 3rd, 2025.With a majority of today’s businesses relying on Artificial Intelligence (AI) and cloud workloads, rising data demands are driving the need for greater speed, capacity and flexibility throughout telecommunications and data center networks. The 1FINITY P300 enables next-generation data center interconnect (DCI), metro, regional, and long-haul transport network owners to address these challenges sustainably and cost-effectively. Fujitsu’s new P-series coherent pluggables are the latest addition to the 1FINITY Ultra Optical System, a hyper-reliable optical portfolio delivering extreme performance and scalability, including currently available 400G ZR/ZR+ pluggable offerings.The 1FINITY P300 is equipped with ECC (Error Checking and Correcting) to automatically correct memory errors and other issues. Additionally, it features two firmware modules for redundancy, allowing continuous operation by switching to the backup firmware in case of a failure.When combined with the Virtuora Network Control portfolio, the 1FINITY P300 host element simplifies the planning, design, and deployment of multi-domain, multi-vendor optical and packet-optical networks, including IPoDWDM. Featuring industry-leading open optical control, design, and automation, it offers an end-to-end network management solution. Future updates to the Virtuora Network Control portfolio will also include pluggable management capabilities for use with third-party routers that support open optical networking. Virtuora software streamlines operational complexity, reduces time to issue resolution, and enhances both network availability and profitability.Fujitsu’s Commitment to the Sustainable Development Goals (SDGs)The Sustainable Development Goals (SDGs) adopted by the United Nations in 2015 represent a set of common goals to be achieved worldwide by 2030.Fujitsu’s purpose — “to make the world more sustainable by building trust in society through innovation” — is a promise to contribute to the vision of a better future empowered by the SDGs.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

SINGAPORE, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has developed and commercialized software for virtualized radio access network (vRAN) base stations. The company aims to provide this software to telecommunications carriers in Japan and internationally, and to deploy more than 50,000 vRAN base stations by fiscal 2026.vRAN is a system that will serve as the foundation for the development of network technologies in the future, including further enhancement of 5G services, optimization and streamlining of operational costs, flexible network design, accelerated area deployment, and collaboration with the Innovative Optical and Wireless Network (IOWN®) concept proposed by NTT. This is expected to facilitate the development and introduction of new technologies through Open RAN, and promote innovation while reducing power consumption.NEC's vRAN achieves carrier-grade network quality that complies with the specifications defined by the O-RAN ALLIANCE (*1). In addition, because it complies with open interface specifications, it is guaranteed to work in conjunction with equipment from different vendors and cloud environments. By using this software, it is possible to achieve a RAN configuration that is optimal for the specifications required by telecommunications carriers. In addition, it uses a fully containerized architecture and is based on 5G hardware base station technology and knowledge that is cloud-native, has a proven track record of large-scale commercial use, and it is compatible with cutting-edge general-purpose servers. Furthermore, it uses Qualcomm Technologies' inline accelerator, the Qualcomm Dragonwing X100, to speed up processing, and achieves the high speed and large capacity communications that are characteristic of 5G.NEC has already deployed a 5G core network (5GC, *2) that uses virtualization technology, and the commercialization of this software for vRAN will enable the construction of a total cloud-native 5G network from the core to the RAN. This will make it possible to provide a high-quality 5G network that can flexibly respond to diverse service requirements.Furthermore, by utilizing this software, resource reallocation through virtualization is possible, enabling as much as a 65% reduction in total device power consumption when compared to existing 5G base station equipment (*3).In addition, NEC has developed a Near Real-time RAN Intelligent Controller (Near-RT RIC) to enhance the functionality of vRAN. This enables dynamic customization of RAN operation in response to diversifying service demands, and enables functional expansion such as quality improvement, SLA guarantees, and power saving (*4). Moreover, when combined with NEC's solutions for advanced network operation management, the construction time for mobile infrastructure can be reduced by approximately 70% compared to conventional methods, enabling large-scale commercial deployment of 5G networks in a short period of time."NEC is excited to announce the commercialization of our vRAN software, which will play a critical role in shaping the future of network technologies," said Takashi Sato, Corporate Senior Vice President at NEC. "Our vRAN solution not only adheres to strict O-RAN ALLIANCE specifications but also leverages open interfaces and a fully containerized architecture to ensure optimal integration with multi-vendor and cloud environments.""We are very pleased to see our strong collaboration with NEC moving forward with commercial deployment of the Virtualized Distributed Unit (vDU) using the Qualcomm Dragonwing X100 accelerator card," said Gerardo Giaretta, VP & GM of 5G RAN Infrastructure, Qualcomm Technologies, Inc. "This collaboration demonstrates our commitment to delivering high-performance, energy-efficient and cost-effective 5G solutions that meet the evolving needs of network operators around the world."Going forward, NEC will continue to work towards providing high-performance 5G networks that are geared towards 5G Advanced and 6G, as well as networks with high scalability and flexibility that can respond to diversifying service requirements.(1) O-RAN ALLIANCE:An international industry organization that promotes standardization with the aim of realizing open and scalable next-generation wireless access networks, including 5G.(2)5G core (5GC)A mobile core network system that accommodates 5G wireless.(3)Based on NEC's evaluation criteria.(4)Press release: NEC Develops Near Real-time RIC for High Performance 5G vRAN www.nec.com/en/press/202502/global_20250221_02.htmlAbout NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) and Mitsubishi Heavy Industries Machinery Systems, Ltd. (MHI-MS), a part of MHI Group will participate in Japan's first trial project for autonomous trucks, to be conducted on a section of the Shin-Tomei Expressway (between Surugawan-Numazu SA/SIC and Hamamatsu SA/SIC) from March 3 by the Road Bureau of Japan's Ministry of Land, Infrastructure, Transport and Tourism (MLIT), the National Institute for Land and Infrastructure Management (NILIM), and Central Nippon Expressway Company Limited (NEXCO Central).(Note1) MHI-MS has developed and delivered the "Merging Support Information System" that will provide data to support merging during the trial project. This system allows autonomous trucks to ascertain the status of traffic on the main highway well before reaching the acceleration lane, allowing them sufficient time to adjust their speed to ensure safe and smooth merging.The Merging Support Information System is a mechanism for "Cooperative Vehicle/Infrastructure System," an important function of autonomous driving assistance infrastructure, allowing vehicles to operate safely at the junction to the main highway, one of the most challenging situations for autonomous vehicles. MHI-MS developed and delivered a vehicle detection sensor system and roadside processing unit. Information on vehicles traveling on the main highway is obtained from sensors placed along the roadway, and transmitted through the roadside processing unit to trucks attempting to merge onto the main highway, supporting safe and smooth merging. Specifically, since the status of vehicles traveling on the main highway can be ascertained before entering the acceleration lane, the trucks are able to determine a target merging point well in advance and adjust their merging speed, reducing the risk of impeding the vehicles traveling on the main highway. In addition, the information provided by the system can be received by non-autonomous vehicles that have a dedicated receiver, such as ETC 2.0, which allows drivers to use a variety of information services in addition to toll collection, and ITS Connect, which allows vehicles to obtain information on surrounding conditions to support driving assistance through direct communication between vehicles.This trial will be conducted by designating a priority lane for autonomous vehicles during late night hours, and operating autonomous trucks on public roads. The verification of the Merging Support Information System, one of the components of the trial, will be conducted by confirming whether the information provided by the roadside unit can be received appropriately. The Japanese government has implemented the "Digital Lifeline Development Plan," which aims to enhance the safety of autonomous driving, and establish an environment for efficient operation.(Note2) This demonstration experiment is part of that effort.MHI Group has developed sensing and communication technologies through toll collection and ETC systems provided in Japan and overseas, and believes that these technologies can be applied to autonomous driving support infrastructure. The Company also took part in the Cooperative Vehicle/Infrastructure System Demonstration Experiment conducted by NEXCO Central in June 2024 on a section of the Shin-Tomei Expressway that has not yet been put into service,(Note3) and the results obtained from that experiment have been applied to the Merging Support Information System. As various services that make full use of CASE technologies(Note4) are being applied more broadly for road traffic, MHI Group, in addition to sensors and other vehicle functions, will support the development of infrastructure to provide roadway-to-vehicle information, and contribute to the establishment of highly safe and convenient next-generation mobility.(1) For more information on the trial for autonomous trucks, see the following press release from MLIT.https://www.mlit.go.jp/report/press/road01_hh_001884.html (Japanese)(2) For more information on the Digital Lifeline Development Plan, see the following press release from METI.https://www.meti.go.jp/policy/mono_info_service/digital_architecture/lifeline_portal/index.html(Japanese)(3) For more information on MHI Group’s participation in the Cooperative Vehicle/Infrastructure System Demonstration Experiment, see the following press release.https://www.mhi.com/news/22100502.html(4) "CASE" is an acronym derived from the words "connected," "autonomous," "shared" and "electric." It refers to the current technological trend in the automotive industry to create next-generation mobility services offering outstanding safety and convenience.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today the launch of the new nutritional drink “Chocola BB® Nightwell” (designated quasi-drug product), a nutritional drink to help recovery from the accumulated fatigue of the day during sleep, on Monday, March 3. The productbelongs to the Chocola BB brand, which supports people’s beauty and health, and will be available at pharmacy and drugstores throughout Japan.Chocola BB Nightwell contains eight active ingredients, including vitamin B2, which supports fatmetabolism and converts it into energy, and glycine, which improves sleep quality associated with poornutrition, as well as herbal medicines (Crataegus oxyacantha and Citrus unshiu peel). With a grapefruit flavor, Chocola BB Nightwell is easy to drink, low in calories (5.1 kcal per bottle), and caffeine-free, allowing consumption before bedtime. By promoting fatigue recovery during sleep, Chocola BB Nightwell supports a refreshed start to the day.Since the launch of Chocola BB tablets in 1952, the Chocola BB brand has been offering products forover 70 years to address various skin and fatigue symptoms, in line with the needs of each era. The current Chocola BB drink lineup consists of designated quasi-drugs for fatigue care, including “ChocolaBB® Light” for daily fatigue, “Chocola BB® Royal 2” for severe fatigue, and “Chocola BB® Hyper” for low vitality.By marketing the Chocola BB series of products, Eisai is committed to addressing the diverse needswithin fatigue care, and supporting the beauty and wellness of even more people.Please refer to the product’s website for details about Chocola BB Nightwell (Japanese only) www.eisai.jp/products/chocola/chocola_bb_nightwellFOr more information, visit https://www.eisai.com/news/2025/news202514.html. Media Inquiries:Public Relations Department, Eisai Co., Ltd.+81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO and CAMBRIDGE, Mass., Mar 3, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. and Biogen Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has reaffirmed its positive opinion by consensus for the anti-Aβ monoclonal antibody lecanemab, adopted in November 2024.(1) Following CHMP’s reaffirmation, after having considered the additional information requested by the European Commission (EC), the EC will resume the decision-making process for lecanemab's marketing authorization.In January 2025, as part of its decision-making process, the EC asked the CHMP to consider information on the safety of lecanemab that became available after the adoption of the CHMP opinion in November 2024 and whether this may require anupdate of the opinion, and to consider whether the wording of the risk minimization measures in the opinion is clear enough to ensure correct implementation. After reviewing the additional information, the CHMP concluded that its positive opinion for lecanemab does not need to be updated.Mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and AD dementia currently affects an estimated 15.2 million and 6.9 million people in Europe, respectively.(2) AD progresses over time in stages with increasingly severe symptoms that greatlyimpact not only those who are living with AD, but also their loved ones, care partners and society. There is a significant unmet need for new treatment options that slow down the progression of AD from its early stage.If the EC approves the lecanemab marketing authorization application, the approval will apply to all 27 European Union member states, as well as Iceland, Liechtenstein, and Norway. Eisai and Biogen will continue to make every effort to deliver lecanemab to patients with early AD in Europe as soon as possible.Eisai serves as the lead for lecanemab’s development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision- making authority.About lecanemab (generic name, brand name: Leqembi®)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab has been approved in the U.S.,(3) Japan,(4) China,(5) South Korea,(6) Hong Kong,(7) Israel,(8) the United Arab Emirates,(9) the United Kingdom,(10) Mexico,(11) Macau and Oman, and is under regulatory review in 17 countries and regions including theEU. In January 2025, the U.S. Food and Drug Administration (FDA) has approved the Supplemental Biologics License Application (sBLA) for once every four weeks maintenance dosing. In January 2025, the submission of a Biologics License Application (BLA) for maintenance dosing of a subcutaneous injection formulation, which is being developed to enhance convenience for patients, was accepted in the U.S.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School ofMedicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of lecanemab development and regulatory submissions globally with both companies co-commercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of ADtreatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on the antibody lecanemab back-up was signed in May 2015.About Eisai Co., Ltd.Eisai's Corporate Concept is "to give first thought to patients and people in the daily living domain, and to increase thebenefits that health care provides." Under this Concept (also known as human health care (hhc) Concept), we aim toeffectively achieve social good in the form of relieving anxiety over health and reducing health disparities. With a global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to create and deliver innovative products to target diseases with high unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.In addition, we demonstrate our commitment to the elimination of neglected tropical diseases (NTDs), which is a target (3.3) of the United Nations Sustainable Development Goals (SDGs), by working on various activities together with global partners.For more information about Eisai, please visit www.eisai.com (for global headquarters: Eisai Co., Ltd.), and connect with us on X, LinkedIn and Facebook. The website and social media channels are intended for audiences outside of the UK and Europe. For audiences based in the UK and Europe, please visit www.eisai.eu and Eisai EMEA LinkedIn. About BiogenFounded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patient’s lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.The company routinely posts information that may be important to investors on its website at www.biogen.com. Follow Biogen on social media – Facebook, LinkedIn, X, YouTube.Biogen Safe HarborThis news release contains forward-looking statements, including about the potential clinical effects of lecanemab; the potential benefits, safety and efficacy of lecanemab; potential regulatory discussions, submissions and approvals and the timing thereof; the treatment of Alzheimer's disease; the anticipated benefits and potential of Biogen's collaboration arrangements with Eisai; the potential of Biogen's commercial business and pipeline programs, including lecanemab; and risks and uncertainties associated with drug development and commercialization. These forward- looking statements may beaccompanied by such words as “aim,” “anticipate,” “assume,” “believe,” “contemplate,” “continue,” “could,” “estimate,”“expect,” “forecast,” “goal,” “guidance,” “hope,”“intend,” “may,” “objective,” “plan,” “possible,” “potential,” “predict,” “project,” “prospect,” “should,” “target,” “will,” “would,” and other words and terms of similar meaning. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage clinicaltrials may not be indicative of full results or results from later stage or larger scale clinical trials and do not ensure regulatory approval. You should not place undue reliance on these statements. Given their forward-looking nature, these statements involve substantial risks and uncertainties that may be based on inaccurate assumptions and could cause actual results to differ materially from those reflected in such statements. These forward-looking statements are based on management's current beliefs and assumptions and on information currently available to management. Given their nature, we cannot assurethat any outcome expressed in these forward-looking statements will be realized in whole or in part. We caution that thesestatements are subject to risks and uncertainties, many of which are outside of our control and could cause future events or results to be materially different from those stated or implied in this document, including, among others, uncertainty of long- term success in developing, licensing, or acquiring other product candidates or additional indications for existing products; expectations, plans and prospects relating to product approvals, approvals of additional indications for our existing products,sales, pricing, growth, reimbursement and launch of our marketed and pipeline products; our ability to effectively implementour corporate strategy; the successful execution of our strategic and growth initiatives, including acquisitions; the risk thatpositive results in a clinical trial may not be replicated in subsequent or confirmatory trials or success in early stage clinicaltrials may not be predictive of results in later stage or large scale clinical trials or trials in other potential indications; risks associated with clinical trials, including our ability to adequately manage clinical activities, unexpected concerns that may arisefrom additional data or analysis obtained during clinical trials, regulatory authorities may require additional information orfurther studies, or may fail to approve or may delay approval of our drug candidates;the occurrence of adverse safety events, restrictions on use with our products, or product liability claims; and any other risksand uncertainties that are described in other reports we have filed with the U.S. Securities and Exchange Commission.These statements speak only as of the date of this press release and are based on information and estimates available to us at this time. Should known or unknown risks or uncertainties materialize or should underlying assumptions prove inaccurate, actual results could vary materially from past results and those anticipated, estimated or projected. Investors are cautioned not to put undue reliance on forward-looking statements. A further list and description of risks, uncertainties and other matterscan be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and in our subsequent reports on Form 10-Q and Form 10-K, in each case including in the sections thereof captioned “Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in our subsequent reports on Form 8-K. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements whether as a result of any new information, future events, changed circumstances or otherwise.(1) Committee for Medicinal Products for Human Use. 2024. Leqembi (Lecanemab).Overview. Available at: www.ema.europa.eu/en/medicines/human/EPAR/leqembi#overview Last accessed: January 2025(2) Gustavsson, A., et al. Global estimates on the number of persons across the Alzheimer's disease continuum. Alzheimer’s & Dementia.2023;19:658-670. https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12694. (3) U.S. Food and Drug Administration. 2023. FDA Converts Novel Alzheimer’s Disease Treatment to Traditional Approval. Last accessed: January 2025.(4) Reuters. 2023. Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen. Last accessed: January 2025.(5) The Pharma Letter. 2024. Brief - Alzheimer drug Leqembi now approved in China. Last accessed: January 2025.(6) Pharmaceutical Technology. 2024. South Korea’s MFDS approves Eisai-Biogen’s LEQEMBI for Alzheimer’s. Last accessed: January 2025.(7) Pharmaceutical Technology. 2024. Hong Kong approves Leqembi for Alzheimer’s treatment. Last accessed: January 2025.(8) Pharmaceutical Business Review. 2024. Leqembi gains approval for Alzheimer’s treatment in Israel. Last accessed: January 2025.(9) United Arab Emirates Ministry of Health & Prevention. 2024. Registered Medical Product Directory. Leqembi. Last accessed: January 2025.(10) Lecanemab United Kingdom Summary of Product Characteristics. Available at: www.medicines.org.uk/emc/product/15908. Last accessed: January 2025.(11) The Pharma Letter. 2024. BRIEF-Mexican approval for Alzheimer’s drug Leqembi. Available at: www.thepharmaletter.com/brief-mexican-approval-for-alzheimers-drug-leqembi. Last accessed: January 2025.MEDIA CONTACTSEisai Co., Ltd.Public Relations Department TEL: +81 (0)3-3817-5120Eisai Europe, Ltd.EMEA Communications Department+44 (0) 797 487 9419Emea-comms@eisai.netEisai Inc. (U.S.)Libby Holman+1-201-753-1945Libby_Holman@Eisai.comBiogen Inc.Jack Cox+ 1-781-464-3260public.affairs@biogen.comINVESTOR CONTACTSEisai Co., Ltd.Investor Relations Department TEL: +81 (0) 3-3817-5122Biogen Inc.Tim Power+ 1-781-464-2442IR@biogen.com Copyright 2025 JCN Newswire via SeaPRwire.com.

KAWASAKI, Japan, Feb 28, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu's Oyama plant, home to its photonics product manufacturing and management division, has achieved a perfect score of 100 (Class A-Excellent) in a supply chain CSR audit conducted by the Joint Alliance for CSR (JAC), demonstrating Fujitsu's strict adherence to global CSR standards across all audit items (labor, safety and health, environment, business ethics, and management systems). Of the 123 companies audited on their record in 2023, only 18% achieved a Class A-Excellent rating of 90 points or higher. This audit was conducted by NTT, a member of JAC, in the presence of KDDI and SoftBank.This perfect score is a reflection of the various distinctive initiatives that Fujitsu’s Oyama plant has implemented. In health and safety, the plant regularly shares natural disaster situation reports and conducts employee training across departments. The photonics manufacturing division maintains a zero accident record as of today, and has logged over 10 million accident-free hours since 2018 (1). Environmentally, the plant participates in the Oyama City Zero Carbon & Nature Positive Promotion Platform, encouraging collaboration with the local authority towards decarbonization, coexistence with nature and in the implementation of energy-saving measures at the manufacturing site. Additionally, at its Oyama plant, Fujitsu manufactures the high-performance 1FINITY Ultra Optical System, which achieves world-leading long-distance transmission of 1.2 terabits per second. It is the world’s-first optical transmission device to use a water-cooling system, which reduces CO2 emissions by 60% compared to previous Fujitsu products.The Fujitsu Group will continue to promote sustainability management, provide sustainable value to JAC member carriers and CSR-conscious customers, and support the global business expansion of its customers.(1) Counted until January 20, 2025About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press Contacts:Fujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Feb 28, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that the company has entered into a license agreement granting the exclusive development and distribution rights for the fibroblast growth factor (FGF) receptor selective tyrosine kinase inhibitor tasurgratinib succinate (generic name, development code: E7090, Japan brand name: TASFYGO®, “tasurgratinib”) in the Greater China region (mainland China, Hong Kong, Macau, and Taiwan, “licensed regions”) to a subsidiary of SciClone Pharmaceuticals (Holdings) Limited (Headquarters: Shanghai, China, “SciClone”). Eisai will maintain the rights to tasurgratinib worldwide outside of the licensed regions and continue to manufacture and market it in Japan, where it has been already launched.Under the terms of this agreement, Eisai will receive a contractual upfront payment. Additionally, Eisai will receive milestone payments based on the progress of development and regulatory approval, as well as sales milestone payments and certain royalties based on sales revenue after the product launch.Tasurgratinib is an orally available novel tyrosine kinase inhibitor that demonstrates selective inhibitory activity against FGFR1, FGFR2 and FGFR3. Tasurgratinib was approved in Japan for the treatment of patients with unresectable biliary tract cancer with FGFR2 gene fusions or rearrangements that progressed after cancer chemotherapy. The medicine was launched in Japan in November 2024. A Phase I clinical trial (ClinicalTrials.gov, NCT04572295(New Window)) is underway in Japan for patients with estrogen receptor-positive and HER2-negative breast cancer.SciClone is a global biopharmaceutical company with an integrated platform for the development and commercialization of innovative therapies for cancer and severe infection, and a strong presence in the Greater China region. Through the conclusion of this agreement, Eisai expects to maximize the value of tasurgratinib in licensed regions, ensuring the earliest possible contribution to patients in need of the medicine.About SciClone PharmaceuticalsStaying true to its original aspiration of “SciClone gives life hope”, SciClone Pharmaceuticals is dedicated to improving patients’ health by providing top-tier healthcare products and services with global standards of care. SciClone Pharmaceuticals has established a product portfolio with differentiated advantages, including a number of first-in-class and best-in-class potential products / pipelines.For more information regarding SciClone Pharmaceuticals, please visit: www.sciclone.com and https://www.eisai.com/news/2025/pdf/enews202512pdf.pdf. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Feb 28, 2025 - (JCN Newswire via SeaPRwire.com) - NEC Corporation (NEC; TSE: 6701) has developed vRAN that supports the interfaces and components newly specified by the O-RAN Alliance for enhancing the security of Open vRAN. The NEC vRAN platform is now being used to verify the performance of SecureRAN (*) provided by CTOne, a subsidiary of Trend Micro, which also supports the specifications of the O-RAN Alliance.As cyberattacks targeting infrastructure providers and others become more sophisticated, measures to address security risks are becoming increasingly important. Open vRAN allows a variety of networks to be applied according to the deployment scenario of the telecommunications carrier, and while it offers a high degree of flexibility, it also requires measures to address threats to the network.In response to this, NEC is aiming to build and operate a safer and more secure network through the introduction and verification of SecureRAN for highly secure and flexible vRAN infrastructure.SecureRAN deploymentSecureRAN constantly references the latest threat information, and by responding immediately to vulnerabilities, it achieves advanced network monitoring and defense that covers the entire application layer of vRAN.NEC has been a member of the O-RAN Alliance since its inception, and has made important contributions to its activities for network openness and standardization.Specifically, NEC has developed highly secure Open vRAN by leveraging its expertise in conventional RAN construction, while also incorporating the O-RAN Alliance's interface components.Going forward, in order to further enhance the security of vRAN, NEC will verify the introduction of SecureRAN, with the aim of strengthening network infrastructure for customers and providing a safe and secure communications base.In addition, through the implementation of these verification tests, NEC will expand its support menu (introduction support, maintenance, operation support, etc.) for the commercial introduction of SecureRAN.(*)SecureRANSecureRAN is an O-RAN security solution developed and provided by CTOne, a subsidiary of Trend Micro. SecureRAN is designed to improve the effectiveness of security measures and ensure sustainable system deployment, providing robust security protection for critical O-RAN assets and AI-driven applications. https://tinyurl.com/3bckm8ry About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

Mazda Motor Corporation's production and sales results for January 2025 are summarized below.I. Production1. Domestic ProductionMazda's domestic production volume in January 2025 increased 22.6% year on year due to increased production of passenger vehicles.[Domestic production of key models in January 2025]CX-5:25,266 units(down 2.0% year on year)MAZDA3:8,479 units(up 33.5%)CX-30:6,571 units(up 6.8%)2. Overseas ProductionMazda's overseas production volume in January 2025 increased 6.4% year on year due to increased production of passenger vehicles.[Overseas production of key models in January 2025]CX-30:14,079 units(down 1.3% year on year)CX-50:10,059 units(up 39.6%)MAZDA3:4,916 units(down 40.3%)II. Domestic SalesMazda's domestic sales volume in January 2025 increased 23.9% year on year due to increased sales of passenger vehicles.Mazda's registered vehicle market share was 4.1% (up 0.8 points year on year), with a 2.4% share of the micro-mini segment (down 0.4 points), and a 3.4% total market share (up 0.3 points).[Domestic sales of key models in January 2025]CX-5:2,339 units(up 116.4% year on year)MAZDA2:2,120 units(up 31.0%)CX-80:1,253 units III. ExportsMazda's export volume in January 2025 increased 14.3% year on year due to increased shipments to North America and other regions.[Exports of key models in January 2025]CX-5:21,848 units(down 4.8% year on year)MAZDA3:6,820 units(up 48.4%)CX-90:5,644 units(up 225.3%)IV. Global SalesMazda's global sales volume in January 2025 increased 1.5% year on year due to increased sales in the U.S., Japan, and other regions.[Global sales of key models in January 2025]CX-5:26,949 units(up 1.0% year on year)CX-30:17,465 units(down 0.3%)MAZDA3:13,090 units(down 28.0%)* Overseas production figures indicate Mazda-brand units coming off the production line (excluding CKD units).* Global production figures are the sum total of domestic and overseas production volumes.* All information in this press release is as of the release date. No updates after that date are reflected. Copyright 2025 JCN Newswire via SeaPRwire.com.

Toyota City, Japan, Feb 27, 2025 - (JCN Newswire via SeaPRwire.com) - Toyota Motor Corporation (Toyota) has announced that it has submitted a progress report on measures to prevent recurrence of model certification application issues to the Ministry of Land, Infrastructure, Transport and Tourism (MLIT) today in light of the correction order the ministry issued on July 31. This report, summarizing actions taken to date, is the second of a series of quarterly reports.Specific progress of recurrence prevention measuresWith the three pillars of "Strengthening Foundations," "Monozukuri," and "Human Development," Toyota has been promoting a review of the structure and system to ensure that each employee is aware of legal compliance and is able to do the job correctly. The company is also promoting onsite management, in which management goes to the genba and promptly takes appropriate action in response to abnormalities.The following concrete actions are being promoted across the Group with set priorities and activity plans.Strengthening FoundationsManagement visiting the operational genba to identify problems and make immediate decisions on how to deal with them.Management grasping staff hardships and efforts at the genba and discussing what it should do at weekly executive-level meetings related to certification.Enhancing internal controls by reinforcing abnormality management in the vehicle development process, strengthening certification operations audits by in-house inspectors, and introducing secondary audits of the abnormality management and auditing operations themselves.Checking the actual genba conditions of certification-related departments, allocating human resources and testing equipment to the Regulations and Certification Department and the Collision Testing Fields, etc.MonozukuriImplemented a new operational approach to ongoing development projects, incorporating measures to prevent recurrence in October 2024.Introduced a system to check the impact on certification operations at each milestone and make management decisions on the impact on certification operations, including the applicable laws and regulations, the scale of certification operations, the certification schedule, and the number of vehicles to be certified, for all vehicle development projects. (As of February 2025, a total of 35 such projects are being conducted.)Implemented discussions on countermeasures for worksite issues 10 times since previous report (22 times in total), reporting to the Board of Directors as appropriate. This system is ongoing.Human DevelopmentExpanding communication between management and employees to include not only development and certification, but also planning, production, sales and other certification-related worksites.Implemented regular communication through messages from the president (total of 14 times).Since February last year, Toyota Chairman Akio Toyoda, who is responsible for the Group, took the lead in calling on Group companies to start Toyota's company-wide TPS training program for Certification Work. The aim of this initiative is to create a better work system through improvement. The president and other members of management are on-site daily at various genba, such as planning, development, design, production, and sales, which are connected to the certification process. This is being done to clarify stagnation factors in each process and to create a system to identify abnormalities.Toyota will continue to make company-wide efforts to prevent the recurrence of certification issues to once again gain the trust of stakeholders. Copyright 2025 JCN Newswire via SeaPRwire.com.

HIROSHIMA, Japan, Feb 27, 2025 - (JCN Newswire via SeaPRwire.com) - Mazda Motor Corporation (Mazda) has announced that it conducted a demonstration operation of a cupola melting furnace (cupola), the core casting facility installed at its Hiroshima Plant, by fully replacing fossil fuels that emit CO2 during combustion with bio-coal briquettes, a biomass fuel derived from coconut shells, and confirmed the stable operation.The operation of a cupola that uses biomass fuel 100% has not been confirmed for social implementation in the world, and the company took on the challenge of conducting the demonstration experiment in collaboration with the foundry industry and local partners. In the future, Mazda will expand the circle of regional cooperation and promote an energy circulation scheme for local production for local consumption, aiming for carbon neutral (CN) operation of cupolas using waste-derived biomass fuels such as bio-coal briquettes by fiscal year 2030.Mazda has been promoting various initiatives to achieve CN at its global plants by 2035 based on the three pillars of "energy conservation," "shifting to renewable energies," and "introducing CN fuels, etc.," with the goal of achieving CN throughout its entire supply chain by 2050.Stable domestic procurement of raw materials is essential for a full conversion to biomass fuels which is in line with "introducing CN fuels," as one of the aforementioned initiatives. In March 2023, Mazda established the Cupola CN Co-creation Working Group by inviting volunteer companies and organizations to conduct research and development for the shift to biomass fuels, the establishment of production methods, and studies on the local procurement of raw materials. While bio-coal briquettes derived from coconut shells were used in the demonstration experiment this time, Mazda has been working to establish a locally produced, locally consumed energy circulation scheme in Hiroshima and neighboring areas, from biomass waste collection to production, with the aim of revitalizing local industries and contributing to the local communities. As part of such activities, Mazda has been collecting spent coffee bean husks from Tully's Coffee Shop*1 (operated by Tully's Coffee Japan Co., Ltd.) and vending machines*2 in the premises of Mazda Headquarters since November 2024, and confirmed through demonstration experiments that it is possible to produce bio-coal briquettes from these bean husks.Going forward, the company will work together with the local community to develop the local production for local consumption energy circulation scheme into a cooperative effort among industry, government, academia, and the private sector to realize stable raw material procurement of and implementation of fuel conversion.Mazda, together with the local communities, will steadily advance its challenge toward the achievement of CN throughout the supply chain in 2050, and contribute to the creation of an affluent society.For inquiries about biomass raw materials and fuel conversion technology for cupola:cupola-cn-info@mazda.co.jp Powertrain Engineering Dept., Production Engineering Div.For media inquiries, please contact below:mazda_hpr@mazda.co.jp Media Relations Dept., Mazda Motor Corporation(1) Franchisee: CULE Co., Ltd., Franchiser: Tully's Coffee Japan Co., Ltd. (2) Operated by Apex West Japan Co., Ltd. Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Feb 27, 2025 - (JCN Newswire via SeaPRwire.com) - Honda Motor Co., Ltd. today announced that the company has been selected for the CDP’s “2024 Climate Change A List” for the second consecutive year. The CDP is an international non-profit organization that facilitates environmental information disclosure, and Honda was selected based on its initiatives in the areas of climate change and environmental transparency. The CDP is a not-for-profit charity that runs the global disclosure system for companies and local governments (cities, states and regions) around the world. The companies and local governments disclose their environmental information using the CDP questionnaire with three separate sectors – climate change, forest and water security. In 2024, more than 24,800 companies, including listed companies that account for more than 66% of global market capitalization, disclosed their environmental information. The CDP assesses the disclosed information on a score of A to D -, and companies with outstanding initiatives are named to the A List. Among more than 24,800 companies which disclosed environmental information for 2024, Honda was included in the short list of the companies making the A List.Honda is aiming to realize carbon neutrality for all products and corporate activities Honda is involved in by 2050. To this end, Honda has been pursuing electrification of its products by setting and disclosing 2030 milestone targets for both the sales ratio of electrified products and the reduction rate of CO2 emissions intensity during product use for motorcycles, automobiles and power products, respectively. In the area of corporate activities, Honda has set and disclosed a target to reduce the total amount of CO2 emissions by 46% from its corporate activities by 2030 compared to the FY2020 level. Working toward this target, Honda has been improving production efficiency, introducing various energy-saving measures, shifting toward the use of low-carbon energy and facilitating the utilization of renewable energy. Honda views these initiatives as leading to the selection of Honda to the Climate Change A list.Honda will strive to realize a carbon-neutral society, while continuing to take a proactive approach to the initiatives to address climate change and the disclosure of its environmental information. Copyright 2025 JCN Newswire via SeaPRwire.com.

Mitsubishi Heavy Industries Australia, Pty. Ltd. (MHI-AUS), the Australian subsidiary of Mitsubishi Heavy Industries, Ltd. (MHI), is expanding its business activities in Canberra to focus on providing support for the country's next general purpose frigate program and to strengthen its business network with related agencies and companies.MHI-AUS will prioritize measures to respond to requests from the Australian government in a timely manner, including providing flexible sales support, gathering information, and conveying information related to MHI products and services. The Japanese government is fully supportive of MHI's involvement in this project.In addition, as defense equipment and technology cooperation between Japan and Australia is progressing, MHI-AUS will promote mutual understanding and cooperation between Mitsubishi Heavy Industries and Australian defense industrial partners to contribute to strengthening Japan-Australia defense cooperation.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

As part of its corporate governance reform, NEC Corporation (NEC; TSE: 6701) shifted to a Company with a Nominating Committee, etc. in fiscal 2023, and has been promoting the separation of oversight and execution and the clarification of the roles of each. In order to further strengthen the monitoring function of the Board of Directors from fiscal 2025, NEC has established a policy to strengthen corporate governance, focusing on the Board structure, CEO succession planning, and the remuneration system.Through this, NEC aims to further increase the transparency and objectivity of management, accelerate business growth, achieve the Mid-term Management Plan 2025, and sustainably enhance corporate value.1. Achieving a compact structure for the Board of DirectorsIn order to further invigorate discussions on medium- to long-term management policies and strategies at Board of Directors meetings, NEC will shift to a more optimal Board structure that is both sufficiently compact and has the necessary career experience and expertise in specialist fields, while also ensuring diversity.(1) Appointment of Independent Outside DirectorsOutside directors are selected for their skills and experience, which contribute to the sustainable growth of the corporate value of the company and enable the status of execution to be appropriately monitored. After the appointment, outside directors are also subject to peer review as part of the evaluation of effectiveness of the Board of Directors each year, and decisions on reappointment or dismissal are made based on the results of this review. However, the number of times they can be reappointed is limited to eight times.(2) Appointment of Inside DirectorsInside directors are selected from representatives of the execution side where substantial authority has been delegated from the Board of Directors. NEC aims to have the optimal structure for a Board of Directors as a Company with a Nominating Committee, etc., by having a minimum number of inside directors, centering on the CEO.2. CEO succession planning and the approach to developing and selecting the management team on the executive sideIn order to continuously and fairly appoint a CEO who will lead the sustainable enhancement of the company's global corporate value, the Nominating Committee and the CEO will work together to implement CEO succession planning while ensuring transparency and objectivity. In addition, the CEO will develop and appoint the necessary personnel for the management team that leads the business based on the company's medium- to long-term strategies.(1) The role of the Nominating Committee and CEO in CEO succession planningThe Nominating Committee is responsible for "determining the appropriate time for CEO succession" and "identifying candidates for the next CEO." It also supports the development of the next generation of management talent by the CEO. In addition, the CEO is responsible for "developing candidates for the next CEO" and "proposing candidates for succession to the Nominating Committee."(2) CEO term of office, decision on reappointment or dismissalIn order for the Nominating Committee to determine the appropriate timing for CEO succession, the CEO's term of office is not fixed. Instead, the Nominating Committee conducts an "evaluation review" each year and determines whether the CEO will be reappointed or dismissed in the following year based on the CEO's intentions, business performance, a 360-degree evaluation of the CEO, as well as the status of the development of the next CEO candidate.(3) Requirements for the next CEO candidateThe Nominating Committee will assess the candidates proposed by the CEO for the CEO successor from the perspective of their necessary management qualities and character as the next CEO, such as "transformational leadership," "vision and communication skills," "sense of responsibility and determination," "development and formation of an optimal management team," "ability to continue learning," and "ethics," and will select them in consideration of the medium-term management plan, management policies, and management environment.(4) Development and appointment of a management team to lead businessWith regard to Corporate Senior Executive Vice President, Corporate Executive Vice President, and Corporate Senior Vice President, including Executive Officers, NEC has been making decisions on reappointment and dismissal on a position-by-position basis every year from the perspective of "the right time, the right place, the right person." From April 2025 onwards, in order to accelerate flexible appointments of executives, including promoting young talent, ensuring diversity, as well as promotions, demotions and reappointments, NEC will thoroughly develop management talent and promote generational change by setting a maximum of three reappointments to the same position as a guideline.3. How remuneration systems should be structured to provide incentives for enhancing corporate valueNEC will establish an executive remuneration system that provides incentives for competing and winning against global competitors, with the aim of enhancing corporate value through the achievement of the Mid-term Management Plan 2025 and the next Mid-term Management Plan, which aims for even greater heights.Specifically, NEC aims to set competitive and superior remuneration levels in line with its growth and to increase the ratio of stock compensation in particular, thereby linking management to a constant awareness of corporate value. To accelerate this movement, NEC will expand its stock compensation system.(1) Introduction of stock compensation for Outside DirectorsIn order to further enhance the sharing of value with shareholders and strengthen awareness of the need for continuous enhancement in corporate value, NEC will introduce a non-performance-based, Restricted Stock Remuneration Plan for outside directors from June 2025.(2) Expansion of stock compensation for Executive Officers and othersIn order to strengthen the sharing of value with shareholders and to secure excellent human resources to take on management roles, in addition to the current performance-based stock compensation, a new non-performance-based Board Incentive Plan Trust will be introduced from April 2025 for Corporate Senior Vice President and above, including Executive Officers and others, and the ratio of stock compensation will be increased.Comment from Harufumi Mochizuki, Chairman of the Nominating CommitteeAs NEC looks to enhance its corporate value on a global scale, the transition to a company with a Nominating Committee etc. was a catalyst for us to discuss the ideal structure for a Board of Directors that will lead to continuous growth in corporate value and the development of the next generation of management for true growth. The selection of directors and support for the development of the next generation of management, including the next CEO, is an important role of the Nominating Committee, and we will continue to operate in a way that contributes to enhancing corporate value.Comment from Masashi Oka, Chairman of the Compensation CommitteeIn addition to achieving the goals of the Mid-term Management Plan 2025, the Compensation Committee has been discussing the direction and form of executive compensation that will serve as an incentive to achieve a competitive advantage globally over the medium to long term during the next Mid-term Management Plan period. As a result, NEC will introduce stock compensation for outside directors and increase the ratio of stock-based compensation for Officers from fiscal 2025, accelerating the strengthening of awareness of sustainable enhancement of corporate value. In addition, NEC will continue to strengthen the design and operation of its remuneration to ensure that it functions as an incentive to enhance corporate value and to secure promising management talent.About NEC CorporationNEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

SINGAPORE, Feb 26, 2025 - (JCN Newswire via SeaPRwire.com) - Olympus Corporation of Asia Pacific Limited (Olympus APAC), the regional headquarters of Olympus Corporation in Asia and Oceania, today announced a milestone for its iTind™ device with expanded availability across major markets in the Asia-Pacific (APAC) region, a move in line with its commitment and purpose of making people’s lives healthier, safer and more fulfilling.iTindAlready marketed in the United States and Europe, the iTind procedure is a minimally invasive solution for the treatment of benign prostatic hyperplasia (BPH), also known as an enlarged prostate. With a launch in Korea scheduled in March, iTind will become available in six1 markets across APAC.“With our upcoming launch in Korea, achieving wider availability of the iTind device in APAC is an important milestone for physicians and patients in our region. We’re excited to provide increased access to a minimally invasive outpatient BPH procedure for suitable patients, addressing a common health problem for men over 50 with the risk of BPH increasing with age. Symptoms of BPH include frequent urination with a sense of urgency and a weak urinary stream and excessive urination at night. The iTind procedure provides a rapid and effective patient-focused treatment option, with the added benefit of the procedure being able to be performed in a clinic room under local anaesthesia, helping ease pressure on hospital capacity.” said Daisuke Goto, Head of Surgical Business at Olympus APAC.As part of the roll-out of the iTind device across the region, Olympus has designed a comprehensive training programme to support Physicians and to maximise the success of incorporating the iTind procedure as part of their clinical practice.Olympus will continue its efforts to accelerate market development of the iTind minimally invasive BPH solution, providing more patients and physicians with access to this novel procedure, strengthening the care pathway and elevating the standard of care for patients with BPH.About iTindThe iTind, a temporarily implantable nitinol device, supports the relief of lower urinary tract symptoms (LUTS) secondary to BPH, offers a minimally invasive alternative for BPH treatment without the need for medications, permanent implants, or tissue removal. This innovative approach provides a short-term treatment option that reshapes the prostatic urethra and improves patient quality of life. In September 2023, the iTind procedure was included in the American Urological Association (AUA) clinical practice guideline for management of LUTS attributed to BPH. In the United States, two new Category I CPT codes2 for the iTind procedure went into effect January 1, 2025, which enable billing for the procedure at all sites of services.1 Thailand, Australia, Hong Kong, Singapore, India, Korea2 Current Procedural Terminology (CPT) code is a numeric code that identifies a medical procedure or service maintained by American Medical Association (AMA). Healthcare professionals use CPT codes to bill for medical services. About OlympusAt Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global X account: @Olympus_Corp.Media contact:Mail: Global-Public_Relations@olympus.comOlympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com Copyright 2025 JCN Newswire via SeaPRwire.com.

Kawasaki and Tokyo, Feb 25, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited, ANA X Inc., Toshiba Data Corporation, and Kawasaki City today announced the launch of a pilot program aimed at achieving a decarbonized society through utilizing each company’s smartphone application. The program will commence from February 27, 2025.This pilot program will utilize a database, developed by the Ministry of the Environment and other companies, to visualize CO2 reductions and provide feedback to residents and workers of Kawasaki City on their CO2 reductions achieved through environmentally conscious actions. This is the first trial in Japan to use this database. The program aims to quantitatively assess citizen environmental actions, promote individual environmental awareness, and contribute to the realization of a decarbonized society.Pilot project overview1. Pilot Period:February 27, 2025 to March 28, 20252. Participants:Residents and workers of Kawasaki City3. Implementation Details:Participants will download one or more participating companies' smartphone applications and register their age, residential area, and other information.Fujitsu's platform will aggregate participants' mobility, purchase and environmental action data from the applications, calculating and visualizing CO2 reductions based on the standardized metric. Participants can view their CO2 reductions resulting from their environmentally conscious actions through Eco Potential, a web application developed by Fujitsu. The aggregation of data from multiple applications into this single application allows for a more efficient and easily understandable evaluation of participants' environmental efforts, fostering sustained positive environmental behavior. The research partners will evaluate the social value of the CO2 reductions created by these systems and determine the key elements needed for wider adoption of the standardized metric.4. Roles:Fujitsu:Development of the platform and the Eco Potential application.Provision of Green Carb0n Club, a Kawasaki City-based application that links real-world environmental actions.Integration of the environmental action data into Eco Potential.ANA X:Provision of ANA Pocket, a mobile application which allows users to earn points and ANA miles for various modes of transportation (walking, cycling, driving, trains, and planes).Integration of the travel data into Eco Potential.Toshiba Data:Provision of data obtained from Toshiba Tec Corporation’s SmartReceipt, an electronic receipt service which digitizes purchased item details typically provided on paper receipts.Integration of the purchase data into Eco Potential.The City of Kawasaki:Providing advisory services aimed at fostering behavioral change among its citizens.Providing and coordinating access to a suitable field test environment.PromotionJapan aims to achieve carbon neutrality by 2050, targeting a 46% reduction in greenhouse gas emissions by FY2030 (compared to FY2013). To achieve this target, a significant reduction in CO2 emission from citizens' daily lives is indispensable.Kawasaki City has set ambitious targets of a 50% reduction in city-wide CO2 emissions and a 45% or greater reduction in household emissions in the city by FY2030 (both compared to FY2013), actively pursuing initiatives to achieve a decarbonized society.Moreover, Fujitsu, ANA X and Toshiba Data have been actively engaged in discussions within the framework of the Ministry of the Environment's ‘Decokatsu’, a national movement to change people's behavior and lifestyles toward the achievement of carbon neutrality.Under this national movement, The POSITIVE ACTION Initiative (PAI), an initiative to create a new and prosperous lifestyle connected to decarbonization, towards creating a world where citizens actively engage in environmental actions. This pilot program serves as the first step in our efforts to promote the early social implementation of the newly developed CO2 reduction standard metric, contributing to our decarbonization initiatives.Future PlansFujitsu, ANA X., Toshiba Data, and Kawasaki City will continue to explore ways to promote citizen’s environmental behavioral change and implement standardized CO2 reduction indicators. The partners will also investigate expanding data integration with Eco Potential and exploring ways to monetize achieved CO2 reductions, such as through voluntary carbon credits and community benefits.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.7 trillion yen (US$26 billion) for the fiscal year ended March 31, 2024 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries (https://tinyurl.com/5n76ynkb) Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Feb 24, 2025 - (JCN Newswire via SeaPRwire.com) - ENEOS Corporation and Mitsubishi Corporation have agreed to jointly conduct a Front End Engineering Design to advance the study of Sustainable Aviation Fuel (“SAF”) production facility at the ENEOS Wakayama Plant in Arida City, Japan (the “FEED”).ENEOS has been studying the feasibility of such a facility since 2022. To advance this study to the next stage, ENEOS and MC, who have been jointly assessing the feasibility on the commercialization of SAF, will work together on the FEED. ENEOS has an established sales network, manufacturing and refining technologies and the expertise in feedstock procurement, while MC has expertise in the procurement of feedstock in Japan and around the world. By combining each companies' respective strengths, ENEOS and MC will accelerate the study with the aim of developing large-scale production of SAF in Japan.The facility, subject to the result of the FEED, is expected to produce approximately 300,000 tons (400,000 KL) of SAF per year from FY2028 onwards, together with bio-naphtha and bio-diesel fuel fractions as byproducts. Its feedstock will include used cooking oil, animal fat, and other wastes and byproducts.ENEOS and MC place a high priority on addressing climate change issues, and both companies are actively promoting initiatives to reduce CO2 emissions with the aim of helping to achieve a decarbonized, circular society. As part of this effort, the companies will move forward with their study on SAF.Reference:(Released on February 21, 2025) ENEOS Selected for the “Support Project for Sustainable Aviation Fuel (SAF) Production and Supply Chain Development”: www.eneos.co.jp/english/newsrelease/2024/pdf/20250221_02.pdf(Released on April 18, 2022) Joint Feasibility Study on the Commercialization ofSustainable Aviation Fuel: www.mitsubishicorp.com/jp/en/news/release/2022/0000048990.htmlInquiry Recipient:Mitsubishi Corporation Press Relations TeamTelephone:+81-3-3210-2171ENEOS Corporation Publlic Relations Department, Media Relations Grouppr@eneos.comTelephone:+81-3-6257-7150 Copyright 2025 JCN Newswire via SeaPRwire.com.

TOKYO, Feb 21, 2025 - (JCN Newswire via SeaPRwire.com) - Honda became the first company in the automotive industry to receive the highest ranking of “3 stars,” as part of the FIA*1 Road Safety Index, set forth by the FIA to enable businesses and organizations to measure their road safety footprint.The 3-star recognition was announced on February 17 at the “Challenge 2030: Achieving the Global Road Safety Goals”, a concurrent event of the 4th Global Ministerial Conference on Road Safety which was held in Marrakech, Morocco, from February 18 through 20, 2025, local time.The FIA Road Safety (RS) Index is a new tool designed to enable companies and organizations to visualize and measure the impact of their operations on road safety and achieve more sustainable road traffic. The Index provides comprehensive assessment and evaluation of the safety footprint of each company/organization based on various factors such as their road safety goals, commitment, and the number of road traffic fatalities and injuries across their entire value chain.Additionally, the FIA RS Index system contains two ratings: 1) the “supply chain rating,” which covers a broad range of corporate activities from procurement of raw materials, to development and production of products, and customer delivery of the products, and 2) the “product/service rating,” which evaluates the safety aspects of products/services. Honda became the first company in the automotive industry to undergo audits for both ratings and received the highest rating, 3 stars(2), in both ratings.Striving to realize a collision-free society for everyone sharing the road, Honda has been committed to pursuing safety initiatives, from both hardware and software perspectives, under the Honda global safety slogan of “Safety for Everyone.” As milestones of its challenge, Honda is striving to reduce the number of traffic collision fatalities involving Honda motorcycles and automobiles worldwide by 50% by 2030(3), then to achieve zero traffic collision fatalities by 2050.Becoming the first automaker to receive 3 stars as part of the FIA RS Index represents Honda’s strong commitment to the pursuit of road safety. Safety initiatives Honda has been conducting based on its long-term safety strategy were highly evaluated, as well as the fact that Honda has been tracking the number of traffic collision fatalities and serious injuries across its value chain, by age and by type of road user, as its road safety footprint.Leveraging the knowledge amassed through its long history of safety initiatives, Honda will proactively support the standardization of indexes for evaluating road safety initiatives. Through such activities, Honda will contribute to solving societal issues centered around road safety from the perspective of ESG (Environmental, Social, and Governance), and continue its pursuit of safety toward the realization of the joy and freedom of mobility and a more enjoyable and sustainable society. (1) Fédération Internationale de lʼAutomobile(2) The scope of Honda operations evaluated by FIA this time is limited to operations related to motorcycle and automobile production and sales in Japan.(3) Reduce traffic collision fatalities involving Honda motorcycles and automobiles per 10,000 units sold by 50% by 2030 compared to 2020.Comments by FIA Secretary General for Automobile Mobility Willem Groenewald“Safety is at the heart of our mission in both motorsport and for the daily road user. Through the FIA Road Safety Index, we help companies measure and improve their impact on road safety. We are pleased to announce that Honda is the first car and motorcycle manufacturer to achieve the Index's highest rating of 3 stars both for its supply chain and safety-related products and services. Honda has demonstrated a strong commitment to fostering a culture of continuous improvement in road safety.”Comments by Hideaki Takaishi, General Manager of Safety Planning Division,Corporate Planning Unit, Honda Motor Co., Ltd.“Honda is honored to have our long-standing safety initiatives recognized through successful completion of the FIA Road Safety Index. For over 50 years, we have focused not only on developing safe motorcycle and automobile products but also on spreading knowledge of safe driving and riding practices among our customers through our awareness-building activities. The FIA Road Safety Index has proven to be a promising tool to objectively evaluate the sincere safety initiatives of Honda. We are expecting that widespread commitment to safety initiatives among more companies and organizations will lead to reduction of traffic collisions around the world.” Copyright 2025 JCN Newswire via SeaPRwire.com.